Grade 1 | Grade 2 | Grade 3 | Grade 4 | |
---|---|---|---|---|
Patients with a treatment-related AE, n (%) | 21 (28.4) | 16 (21.6) | 7 (9.5) | 1 (1.4) |
All events by maximum reported grade, n | ||||
Any | 68 | 23 | 7 | 1 |
Pruritus | 10 | 3 | ||
Diarrhoea | 6 | 4 | 2 | |
Pain | 7 | 2 | 2 | |
Fever | 8 | 1 | 1 | |
Anaemia | 6 | 1 | ||
Rash | 5 | 2 | ||
Nausea | 6 | |||
Asthenia | 5 | |||
Cough | 2 | |||
Dyspnoea | 1 | 1 | ||
Hyperthyroidism | 2 | |||
Hypothyroidism | 2 | |||
Infection | 2 | |||
Scrotal pain | 1 | 1 | ||
Dermatitis | 1 | |||
Oedema | 1 | |||
Epigastric pain | 1 | |||
Herpes Zoster | 1 | |||
Hypocalcemia | 1 | |||
Increase in aspartate transaminase/alanine transaminase | 1 | |||
Pancytopenia | 1 | |||
Other* | 9 |